Novel pyrazolo[1,5-a]pyridines as PI3K inhibitors: variation of the central linker group

被引:14
|
作者
Kendall, Jackie D. [1 ,2 ]
Marshall, Andrew J. [1 ]
Giddens, Anna C. [1 ]
Tsang, Kit Yee [1 ]
Boyd, Maruta [1 ]
Frederick, Raphael [1 ]
Lill, Claire L. [3 ]
Lee, Woo-Jeong [3 ]
Kolekar, Sharada [3 ]
Chao, Mindy [3 ]
Malik, Alisha [3 ]
Yu, Shuqiao [3 ]
Chaussade, Claire [2 ,3 ]
Buchanan, Christina M. [2 ,3 ]
Rewcastle, Gordon W. [1 ,2 ]
Baguley, Bruce C. [1 ,2 ]
Flanagan, Jack U. [1 ,2 ]
Denny, William A. [1 ,2 ]
Shepherd, Peter R. [2 ,3 ]
机构
[1] Univ Auckland, Sch Med & Hlth Sci, Auckland Canc Soc Res Ctr, Auckland 1142, New Zealand
[2] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand
[3] Univ Auckland, Sch Med & Hlth Sci, Dept Mol Med & Pathol, Auckland 1142, New Zealand
关键词
KINASE-INHIBITORS; PATHWAY INHIBITORS; P110-ALPHA; THIOAMIDES; DISCOVERY; CANCER; DESIGN;
D O I
10.1039/c3md00221g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As part of our investigation into the pyrazolo[1,5-a] pyridines as novel PI3K inhibitors, we report a range of analogues where the central linker portion of the molecule was varied while retaining the pyrazolo[1,5-a] pyridine and arylsulfonyl or arylcarbonyl groups. Isostere generating software BROOD was used to assist with producing ideas. The isoform selectivity of the compounds varied from pan-PI3K for compound 41 to p110 alpha-selective for compound 58 or p110 delta-selective for compound 57. The latter two compounds varied only in their sulphur oxidation state.
引用
收藏
页码:41 / 46
页数:6
相关论文
共 50 条
  • [41] Novel PI3K Inhibitors Enter Human Studies
    不详
    CANCER DISCOVERY, 2012, 2 (05)
  • [42] Synthesis and biological evaluation of 7-(aminoalkyl)pyrazolo[1,5-a] pyrimidine derivatives as cathepsin K inhibitors
    Petek, Nejc
    Stefane, Bogdan
    Novinec, Marko
    Svete, Jurij
    BIOORGANIC CHEMISTRY, 2019, 84 : 226 - 238
  • [43] Preparation of some novel 3,5-diaminopyrazole, pyrazolo-[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]-pyrimidine derivatives containing sulfonamido moieties as antimicrobial agents
    El-Gaby, MSA
    Taha, NM
    Micky, JA
    El-Sharief, MAMS
    ACTA CHIMICA SLOVENICA, 2002, 49 (01) : 159 - 171
  • [44] Identification of pyrazolo[1,5-a]pyrimidine-3-carboxylates as B-Raf kinase inhibitors
    Gopalsamy, Ariamala
    Ciszewski, Greg
    Hu, Yongbo
    Lee, Frederick
    Feldberg, Larry
    Frommer, Eileen
    Kim, Steven
    Collins, Karen
    Wojciechowicz, Donald
    Mallon, Robert
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (10) : 2735 - 2738
  • [45] Chemistry of 2-arylhydrazonopropanals:: Novel synthesis of 1,6-dihydropyridazines and 5-heteroaryl substituted pyrazolo[1,5-a]pyrimidines and pyrazolo [3,4-b]pyridines
    Abdel-Khalik, MM
    Agamy, SM
    Elnagdi, MH
    SYNTHESIS-STUTTGART, 2001, (12): : 1861 - 1865
  • [46] New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors
    Abdallah, Amira E. M.
    Elgemeie, Galal H.
    MEDICINAL CHEMISTRY, 2022, 18 (09) : 926 - 948
  • [47] Chemistry of 2-arylhydrazonopropanals: Novel synthesis of 1,6-dihydropyridazines and 5-heteroaryl substituted pyrazolo[1,5-a]pyrimidines and pyrazolo[3,4-b]pyridines
    Abdel-Khalik, M.M.
    Agamy, S.M.
    Elnagdi, M.H.
    Synthesis, 2001, (12) : 1861 - 1865
  • [48] Novel pyrazolo[1,5-a]pyrimidines as c-Src kinase inhibitors that reduce IKr channel blockade
    Mukalyama, Harunobu
    Nishimura, Toshihiro
    Kobayashi, Satoko
    Komatsu, Yoshimitsu
    Kikuchi, Shinji
    Ozawa, Tomonaga
    Kamada, Noboru
    Ohnota, Hideki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (02) : 909 - 921
  • [49] Design, synthesis and molecular docking of novel pyrazolo [1,5-a] [1,3,5] triazine derivatives as CDK2 inhibitors
    Oudah, Khulood H.
    Najm, Mazin A. A.
    Samir, Nermin
    Serya, Rabah A. T.
    Abouzid, Khaled A. M.
    BIOORGANIC CHEMISTRY, 2019, 92
  • [50] Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors
    Ma, Chen-Chen
    Liu, Zhao-Peng
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (03) : 395 - 403